Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Identifying preliminary domains to detect and measure rheumatoid arthritis flares: report of the OMERACT 10 RA Flare Workshop.

Bingham CO 3rd, Alten R, Bartlett SJ, Bykerk VP, Brooks PM, Choy E, Christensen R, Furst DE, Hewlett SE, Leong A, May JE, Montie P, Pohl C, Sanderson TC, Strand V, Woodworth TG; OMERACT RA Flare Definition Working Group.

J Rheumatol. 2011 Aug;38(8):1751-8. doi: 10.3899/jrheum.110401.

PMID:
21807797
2.

Developing a construct to evaluate flares in rheumatoid arthritis: a conceptual report of the OMERACT RA Flare Definition Working Group.

Alten R, Pohl C, Choy EH, Christensen R, Furst DE, Hewlett SE, Leong A, May JE, Sanderson TC, Strand V, Woodworth TG, Bingham CO 3rd; OMERACT RA Flare Definition Working Group.

J Rheumatol. 2011 Aug;38(8):1745-50. doi: 10.3899/jrheum.110400.

PMID:
21807796
3.

Patient perspective workshop: moving towards OMERACT guidelines for choosing or developing instruments to measure patient-reported outcomes.

Kirwan JR, Fries JF, Hewlett SE, Osborne RH, Newman S, Ciciriello S, van de Laar MA, Dures E, Minnock P, Heiberg T, Sanderson TC, Flurey CA, Leong AL, Montie P, Richards P.

J Rheumatol. 2011 Aug;38(8):1711-5. doi: 10.3899/jrheum.110391.

PMID:
21807790
4.

Domains selection for patient-reported outcomes: current activities and options for future methods.

Tugwell PS, Petersson IF, Boers M, Gossec L, Kirwan JR, Rader T, Sanderson TC, van de Laar MA, Ueffing E, Witter JP.

J Rheumatol. 2011 Aug;38(8):1702-10. doi: 10.3899/jrheum.110389.

PMID:
21807789
5.

The impact triad (severity, importance, self-management) as a method of enhancing measurement of personal life impact of rheumatic diseases.

Sanderson TC, Hewlett SE, Flurey C, Dures E, Richards P, Kirwan JR.

J Rheumatol. 2011 Feb;38(2):191-4. doi: 10.3899/jrheum.100700. No abstract available.

PMID:
21285178
6.

Progress on incorporating the patient perspective in outcome assessment in rheumatology and the emergence of life impact measures at OMERACT 9.

Kirwan JR, Newman S, Tugwell PS, Wells GA, Hewlett S, Idzera L, Laslo B, March LM, Minnock P, Montie P, Nicklin J, Rader T, Richards P, Sanderson TC, Suarez-Almazor M, Tanjong-Ghogomu E, Ueffing E, Welch V.

J Rheumatol. 2009 Sep;36(9):2071-6. doi: 10.3899/jrheum.090360.

PMID:
19738216
7.

Detection of N-terminal pro-corticotrophin releasing hormone (CRH) and a 'novel' CRH in human maternal plasma and placenta.

Sanderson TC, Woods RJ, Kemp CF, Lowry PJ.

Placenta. 2000 Mar-Apr;21(2-3):218-25.

PMID:
10736245

Supplemental Content

Loading ...
Support Center